Group 1 | Group 2 | Group 3 | Group 4 | |
---|---|---|---|---|
Without CKD and without depression | Without CKD and with depression | With CKD and without depression | With CKD and with depression | |
Number of Participants | 18,334 | 1695 | 3928 | 455 |
Age, year | 44.3 (0.3) | 44.1 (0.5) | 60.2 (0.5) | 56.2 (0.9) |
Male, % | 52.0 (0.4) | 36.4 (1.6) | 43.7 (1.1) | 32.1 (2.6) |
Race/ethnicity, % | ||||
Mexican American | 13.5 (1.0) | 16.1 (1.6) | 11.2 (1.0) | 16.0 (2.1) |
Non-Hispanic white | 70.0 (1.5) | 64.8 (2.2) | 72.2 (1.5) | 61.5 (3.0) |
Non-Hispanic black | 10.1 (0.8) | 13.2 (1.2) | 11.6 (0.9) | 18.2 (2.1) |
Other | 6.5 (0.4) | 5.9 (0.7) | 5.0 (0.5) | 4.3 (1.1) |
Education, % | ||||
Less than high school | 15.7 (0.7) | 27.2 (1.6) | 23.1 (0.9) | 35.5 (3.1) |
High school graduate | 22.6 (0.6) | 27.2 (1.5) | 25.6 (1.2) | 25.9 (2.9) |
Some college | 31.6 (0.6) | 33.1 (1.5) | 29.4 (1.0) | 32.0 (3.0) |
College graduate or higher | 30.1 (1.0) | 12.5 (1.4) | 22.0 (1.2) | 6.6 (1.8) |
Current smoke, % | 20.4 (0.6) | 40.7 (1.8) | 15.8 (0.7) | 33.9 (3.2) |
Current excessive alcohol use, % | 11.8 (0.4) | 15.2 (1.0) | 6.2 (0.6) | 9.0 (1.5) |
Antidepressant medication, % | 19.7 (0.6) | 48.6 (2.1) | 18.2 (0.9) | 45.0 (3.1) |
Obesity, % | 33.1 (0.6) | 44.3 (1.7) | 41.7 (1.1) | 55.6 (3.2) |
Hypertension, % | 40.1 (0.6) | 44.8 (1.5) | 72.5 (1.0) | 74.9 (2.8) |
Diabetes, % | 6.8 (0.2) | 11.7 (1.2) | 26.8 (1.0) | 39.8 (2.5) |
Dyslipidemia, % | 24.8 (0.5) | 29.0 (1.6) | 45.8 (1.2) | 48.2 (3.2) |
History of CVD, % | 5.4 (0.2) | 12.6 (1.0) | 23.2 (1.0) | 36.4 (3.1) |
History of Cancer, % | 8.3 (0.3) | 11.7 (1.1) | 17.1 (0.7) | 14.4 (2.2) |
eGFR, mL/min/1.73 m2 | 98.1 (0.3) | 99.3 (0.6) | 72.8 (0.7) | 76.0 (1.8) |
Albumin-to-creatinine ratio, mg/g | 7.6 (0.1) | 8.3 (0.2) | 155.0 (10.1) | 269.9 (35.4) |